The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It · Dr. Amie Hornaman

596. Does Hormone Replacement Cause Cancer? 3 Top Doctors Weigh In

January 16, 2026·1 hr 4 min·5 clips
Estrogen receptors on breast cells are normal, not a sign that estrogen causes cancer, as many doctors mistakenly believe.
This episode features host Dr. Amie Hornaman alongside three expert guests: Dr. Lindsey Berkson, Dr. Jen Simmons, and Dr. Julie Taguchi, who specialize in hormone therapy and oncology. They directly confront the pervasive fear that hormone replacement therapy (HRT) causes cancer, aiming to dismantle decades of medical misinformation. The discussion centers on interpreting flawed studies and presenting modern, nuanced science on hormone safety. The panel meticulously deconstructs the infamous 2002 Women's Health Initiative (WHI) study, which used non-bioidentical drugs like Premarin and medroxyprogesterone acetate. They clarify that the reported "26% increased risk" of breast cancer translated to only about eight more cases among thousands of women, a minuscule absolute risk. Dr. Berkson explains the "timing hypothesis," noting women started on HRT within ten years of menopause showed cardiovascular benefit, while those started later did not. The conversation covers the protective roles of bioidentical progesterone for bone density and testosterone for muscle mass and insulin sensitivity. A striking insight is that normal breast tissue naturally has estrogen and progesterone receptors, and receptor-positive cancers are not an automatic contraindication for HRT. The doctors argue that lifestyle factors like metabolic health, toxicity, and alcohol use are more significant cancer risks than bioidentical hormones. They reveal that in the WHI study's estrogen-only arm, participants actually had 25% fewer breast cancers than the placebo group, a fact rarely publicized. Dr. Simmons shares unpublished data on her "rhythmic dosing" protocol for breast cancer survivors, observing no increased recurrence. The tone is educational, assertive, and deeply empathetic toward women who have suffered due to fear-based medicine. The style is a conversational panel discussion, blending clinical expertise with a mission to empower listeners with actionable truth. Women hesitant about HRT due to cancer fears, or those tired of being dismissed by conventional doctors, will find this episode revolutionary. Listeners seeking a simplistic, anti-all-hormones narrative or those uncomfortable with challenging mainstream medical advice might choose to skip it.

As heard by us

A blunt, practical hormone discussion that ties fear to screening choices and personal risk.

The episode treats hormones less as a simple yes-or-no question and more as part of a broader effort to age better. It is strongest when it moves past general frustration and into concrete screening choices, giving the conversation some real footing.

Read the full review in PlayNext →

Why you'd press play

If hormone fears are making you second-guess screening, this episode pushes for a more personalized answer.

Read the full recommendation in PlayNext →
Listen to the show on